A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Clinical trial NCT06667700 · RECRUITING

Trial details

NCT number: NCT06667700
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Coronavirus Disease (COVID-19)

Start date: 2024-12-02
Primary completion: 2031-01-26
Enrollment: 3082

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.